Technology News and Research

RSS

FDA clears IDEV 6Fr SUPERA VERITAS Transhepatic Biliary Stent System

IDEV Technologies, Incorporated, today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.

10 Nov 2011

ZOLL to display resuscitation technology, temperature management solutions at AHA 2011

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that 27 scientific presentations related to ZOLL products and technology are scheduled to be presented during the American Heart Association (AHA) 2011 Resuscitation Science Symposium (ReSS) and Scientific Sessions.

10 Nov 2011

FDA testing of imported seafood inadequate

Finfish, shrimp, and seafood products are some of the most widely traded foods and about 85 percent of seafood consumed in the U.S. is imported. A new study by researchers from the Johns Hopkins Center for a Livable Future at the Bloomberg School of Public Health shows that testing of imported seafood by the U.S. Food and Drug Administration (FDA) is inadequate for confirming its safety or identifying risks.

10 Nov 2011

Inadequate car seat support may trigger back pain

Inadequate car seat support may be responsible for triggering back pain, reports Edmunds.com, the premier online resource for automotive information. And while there are improvised ways to ease and prevent back discomfort - like purchasing an inflatable pillow or moldable seat supports - most new cars now offer technically advanced lumbar support adjustments.

10 Nov 2011

States cope with health law's MLR, insurance exchange requirements

Georgia was granted some delay in the law's MLR requirements, and in Tennessee and Minnesota, insurance exchange decisions are slowly being made.

10 Nov 2011

Mylan acquires rights to Pfizer's inhalation technology platform

Mylan Inc. today announced that it has entered into an agreement with Pfizer for the exclusive worldwide rights to develop, manufacture and commercialize Pfizer's generic equivalent to GlaxoSmithKline's Advair Diskus and Seretide Diskus incorporating Pfizer's proprietary dry powder inhaler delivery platform.

10 Nov 2011

World-renowned cardiologist receives 2011 TCT Career Achievement Award

Eric J. Topol, MD, a world-renowned cardiologist and physician-scientist, was presented the 2011 TCT Career Achievement Award in a ceremony held today during the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

10 Nov 2011

U of T, UHN launch Techna Institute to develop new healthcare technologies

The Techna Institute, an innovation hub poised to integrate and fast track research, development and commercialization of new healthcare technologies, launches today at University Health Network (UHN) and the University of Toronto.

10 Nov 2011

Clinilabs to utilize NewCardio's QTinno in Phase I trial of new CNS drug

NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that its strategic partner, Clinilabs, will utilize QTinno, NewCardio's automated cardiac safety solution, to conduct a Phase I trial of an investigational new drug under development for a central nervous system (CNS) indication.

10 Nov 2011

Medtronic initiates enrollment in Enlite Sensor study for diabetes

Medtronic, Inc. today announced a new United States investigational device exemption study to evaluate the accuracy of six-day use in adults with diabetes of its Enlite Sensor, the company's latest innovation in continuous glucose monitoring (CGM) technology for people with diabetes.

From Medtronic 10 Nov 2011

DATATRAK third quarter revenue increases 13% to $2.1 million

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its operating results for the third quarter of 2011.

10 Nov 2011

Transgenomic third quarter total revenue increases 87% to $8.3 million

Transgenomic, Inc. today reported financial results for the three and nine months ended September 30, 2011 and provided a business update.

10 Nov 2011

JMC launches comprehensive lung cancer program

Recruiting one of the nation's leading specialists in minimally-invasive lung and chest surgery, Jupiter Medical Center (JMC) has launched the first comprehensive program in Palm Beach and Martin counties dedicated to prevention, early detection, treatment and care of patients with lung cancer and other diseases of the chest and lung.

10 Nov 2011

Simple portable test can diagnose 'vegetative' patients with consciousness

The Coma Science Group, led by Dr Steven Laureys, has developed, along with its partners in London, Ontario, (Canada) and Cambridge (England), a portable test which will permit a simpler and less expensive diagnosis of 'vegetative' patients who still have consciousness, despite the fact that they do not have the means to express it.

9 Nov 2011

ACADIA third quarter revenues decrease to $584,000

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the third quarter ended September 30, 2011.

9 Nov 2011

Idera third quarter net loss increases to $5.5 million

Idera Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2011. Idera is a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like receptors (TLRs).

9 Nov 2011

First Edition: November 9, 2011

In today's headlines, reports on the latest developments related to the 'super committee's' deliberations, an appeals court issues a health law decision and results from yesterday's elections.

9 Nov 2011

Accretive Health third quarter net services revenue increases 38% to $218.9 million

Accretive Health, Inc., a leading provider of comprehensive end-to-end healthcare revenue cycle management services and population health management services infrastructure, today announced financial results for the third quarter ended September 30, 2011.

9 Nov 2011

CU Denver researchers awarded Grand Challenges Explorations grant

The University of Colorado Denver announced today that it will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to test unorthodox ideas that address persistent health and development challenges.

9 Nov 2011

Genetic sequencing key to fundamentally understanding diseases

What started back in 2004 as a three-person start-up may well be on its way to becoming a multi-million euro success story. Advanced by a team of young Dutch scientists pushing disruptive biotech innovations onto the market, the SME FlexGen is attracting the attention of some key investors and demonstrating the added value that public support can offer to innovative SMES, with the Eurostars funding programme leading the way.

9 Nov 2011